SEC Form 4 · accession 0001144204-18-036313
Bionik Laboratories Corp. · BNKL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Remi Gaston-Dreyfus
Director · 10% Owner
Period of report
Jun 13, 2018
Accepted (ET)
Jun 28, 2018 · 2:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001508381
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 13, 2018 | C | 15,740,728 | $0.0625 | A | 91,204,117 | I | Shares held through RGD Investissements and Lombard International Assurance SA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As previously disclosed by the reporting person on a Form 4, filed with the Securities and Exchange Commission on April 3, 2018, as of March 31, 2018, the Issuer became obligated to issue 15,740,728 shares of common stock (the "Shares") to RGD Investissements, an affiliate of the reporting person, as a result of the conversion of certain outstanding convertible promissory notes in accordance with their terms. The reporting person is filing this Form 4 to disclose that the Issuer issued the Shares as of June 13, 2018.